RENB
Price
$0.22
Change
-$0.01 (-4.35%)
Updated
Sep 3 closing price
Capitalization
51.27M
SNBIF
Price
$16.45
Change
+$2.17 (+15.20%)
Updated
Aug 6 closing price
Capitalization
1.18B
Interact to see
Advertisement

RENB vs SNBIF

Header iconRENB vs SNBIF Comparison
Open Charts RENB vs SNBIFBanner chart's image
Renovaro
Price$0.22
Change-$0.01 (-4.35%)
Volume$609.13K
Capitalization51.27M
Sanbio
Price$16.45
Change+$2.17 (+15.20%)
Volume$500
Capitalization1.18B
RENB vs SNBIF Comparison Chart in %
Loading...
RENB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RENB vs. SNBIF commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RENB is a StrongBuy and SNBIF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (RENB: $0.23 vs. SNBIF: $16.45)
Brand notoriety: RENB and SNBIF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RENB: 64% vs. SNBIF: 111%
Market capitalization -- RENB: $51.27M vs. SNBIF: $1.18B
RENB [@Biotechnology] is valued at $51.27M. SNBIF’s [@Biotechnology] market capitalization is $1.18B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RENB’s FA Score shows that 0 FA rating(s) are green whileSNBIF’s FA Score has 0 green FA rating(s).

  • RENB’s FA Score: 0 green, 5 red.
  • SNBIF’s FA Score: 0 green, 5 red.
According to our system of comparison, SNBIF is a better buy in the long-term than RENB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RENB’s TA Score shows that 4 TA indicator(s) are bullish while SNBIF’s TA Score has 2 bullish TA indicator(s).

  • RENB’s TA Score: 4 bullish, 4 bearish.
  • SNBIF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, SNBIF is a better buy in the short-term than RENB.

Price Growth

RENB (@Biotechnology) experienced а -1.22% price change this week, while SNBIF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +16.10%, and the average quarterly price growth was +32.67%.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNBIF($1.18B) has a higher market cap than RENB($51.3M). SNBIF YTD gains are higher at: 253.763 vs. RENB (-72.771). RENB has higher annual earnings (EBITDA): -56.89M vs. SNBIF (-2.99B). RENB (0) and SNBIF (0) have equivalent revenues.
RENBSNBIFRENB / SNBIF
Capitalization51.3M1.18B4%
EBITDA-56.89M-2.99B2%
Gain YTD-72.771253.763-29%
P/E RatioN/AN/A-
Revenue00-
Total Cash1.63MN/A-
Total Debt7.03MN/A-
FUNDAMENTALS RATINGS
RENB vs SNBIF: Fundamental Ratings
RENB
SNBIF
OUTLOOK RATING
1..100
5646
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
96
Overvalued
PROFIT vs RISK RATING
1..100
10085
SMR RATING
1..100
9799
PRICE GROWTH RATING
1..100
9334
P/E GROWTH RATING
1..100
10065
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNBIF's Valuation (96) in the null industry is in the same range as RENB (98) in the Financial Conglomerates industry. This means that SNBIF’s stock grew similarly to RENB’s over the last 12 months.

SNBIF's Profit vs Risk Rating (85) in the null industry is in the same range as RENB (100) in the Financial Conglomerates industry. This means that SNBIF’s stock grew similarly to RENB’s over the last 12 months.

RENB's SMR Rating (97) in the Financial Conglomerates industry is in the same range as SNBIF (99) in the null industry. This means that RENB’s stock grew similarly to SNBIF’s over the last 12 months.

SNBIF's Price Growth Rating (34) in the null industry is somewhat better than the same rating for RENB (93) in the Financial Conglomerates industry. This means that SNBIF’s stock grew somewhat faster than RENB’s over the last 12 months.

SNBIF's P/E Growth Rating (65) in the null industry is somewhat better than the same rating for RENB (100) in the Financial Conglomerates industry. This means that SNBIF’s stock grew somewhat faster than RENB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RENBSNBIF
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
14%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
14%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
14%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
8%
Advances
ODDS (%)
Bullish Trend 8 days ago
87%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
23%
View a ticker or compare two or three
Interact to see
Advertisement
RENB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FWRLX12.41N/A
N/A
Fidelity Select Wireless
HDGVX37.02-0.16
-0.43%
Hartford Dividend and Growth R6
NGUAX32.22-0.21
-0.65%
Neuberger Berman Large Cap Growth Inv
BUIIX23.16-0.34
-1.45%
Buffalo International Institutional
GRECX10.09-0.18
-1.75%
Goldman Sachs Real Estate Securities C

RENB and

Correlation & Price change

A.I.dvisor tells us that RENB and XBIT have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RENB and XBIT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RENB
1D Price
Change %
RENB100%
-4.41%
XBIT - RENB
32%
Poorly correlated
-4.43%
TNGX - RENB
30%
Poorly correlated
-0.75%
ENVB - RENB
29%
Poorly correlated
-3.54%
FBLG - RENB
27%
Poorly correlated
+5.30%
CDXS - RENB
27%
Poorly correlated
-8.06%
More

SNBIF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNBIF has been loosely correlated with AZTR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SNBIF jumps, then AZTR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNBIF
1D Price
Change %
SNBIF100%
N/A
AZTR - SNBIF
46%
Loosely correlated
-9.16%
RENB - SNBIF
34%
Loosely correlated
-4.41%
ANTX - SNBIF
33%
Loosely correlated
+4.55%
SONN - SNBIF
28%
Poorly correlated
-2.46%
RZLT - SNBIF
5%
Poorly correlated
+0.70%
More